Exclusive: Mednax Inc Institutional Investor Sentiment Worsened in Q2 2016

November 29, 2016 - By Clifton Ray   ·   0 Comments

Exclusive: Mednax Inc Institutional Investor Sentiment  Worsened in  Q2 2016

Sentiment for Mednax Inc (NYSE:MD)

Mednax Inc (NYSE:MD) institutional sentiment decreased to 0.77 in Q2 2016. Its down -0.34, from 1.11 in 2016Q1. The ratio dropped, as 170 investment managers increased and started new equity positions, while 153 decreased and sold positions in Mednax Inc. The investment managers in our partner’s database now own: 82.31 million shares, down from 85.10 million shares in 2016Q1. Also, the number of investment managers holding Mednax Inc in their top 10 equity positions increased from 3 to 5 for an increase of 2. Sold All: 32 Reduced: 121 Increased: 128 New Position: 42.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The company has a market cap of $6.14 billion. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital neonatal intensive care units , to babies born prematurely or with medical complications. It has a 18.11 P/E ratio. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice.

About 161,104 shares traded hands. MEDNAX Inc (NYSE:MD) has declined 9.25% since April 26, 2016 and is downtrending. It has underperformed by 14.51% the S&P500.

Analysts await MEDNAX Inc (NYSE:MD) to report earnings on February, 2. They expect $1.00 EPS, down 6.54% or $0.07 from last year’s $1.07 per share. MD’s profit will be $92.91 million for 16.50 P/E if the $1.00 EPS becomes a reality. After $1.07 actual EPS reported by MEDNAX Inc for the previous quarter, Wall Street now forecasts -6.54% negative EPS growth.

According to Zacks Investment Research, “Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives.”

MEDNAX Inc (NYSE:MD) Ratings Coverage

Ratings analysis reveals 44% of MEDNAX’s analysts are positive. Out of 9 Wall Street analysts rating MEDNAX, 4 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $64 while the high is $91.0. The stock’s average target of $76.86 is 16.37% above today’s ($66.05) share price. MD was included in 18 notes of analysts from July 31, 2015. The firm has “Neutral” rating given on Wednesday, November 9 by Mizuho. The stock of MEDNAX Inc (NYSE:MD) has “Buy” rating given on Friday, October 28 by Mizuho. The firm has “Hold” rating given on Monday, September 7 by Zacks. The rating was initiated by JP Morgan on Wednesday, September 16 with “Overweight”. On Tuesday, March 8 the stock rating was maintained by Stifel Nicolaus with “Buy”. The company was maintained on Tuesday, August 25 by Stifel Nicolaus. The firm has “Buy” rating by Jefferies given on Friday, August 26. The stock of MEDNAX Inc (NYSE:MD) has “Neutral” rating given on Friday, October 2 by Citigroup. The company was upgraded on Monday, August 31 by Zacks. The firm has “Neutral” rating by Susquehanna given on Monday, March 7.

MD Company Profile

MEDNAX, Inc., incorporated on October 10, 2007, is a well-known provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 1,150 affiliated physicians who provide anesthesia care to patients in connection with surgical and other procedures, as well as pain management. It has over 255 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. The Company’s network also includes other pediatric subspecialists, including over 140 physicians providing pediatric cardiology care, 120 physicians providing pediatric intensive care, 100 physicians providing hospital pediatric care and approximately 20 physicians providing pediatric surgical care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>